Introduction
The interaction of proteins and other macromolecules with the surface of nanoparticles has been shown to result in marked changes to the physical properties of the nanoparticles as well as the structure and function of the proteins (Monopoli et al., 2012; Walkey and Chan, 2012) . The corona that forms around nanomaterials is comprised of low affinity, rapidly exchanging proteins and high affinity, slowly exchanging proteins. The bound proteins can undergo structural rearrangements that alter their function, increase cell-surface receptor binding and uptake, or induce undesirable effects such as inflammation, oxidative stress and cell death. Much of our understanding of the nanoparticle-protein corona has been derived from studies using extracellular media, such as plasma or serum. Less is known about the effect of nanoparticles on intracellular proteins, although many different nanoparticles are taken up into cells (Ryan et al., 2007; Wu et al., 2009; Zhao et al., 2011) . Some nanoparticles have already been shown to bind tightly to intracellular proteins such as actin and vimentin (Ehrenberg and McGrath, 2005) . Cellular enzymes, particularly those localized to the cytoplasm, will be exposed to nanoparticles that migrate through the cell following uptake. The non-covalent adsorption of enzymes onto various nanoparticles may have profound effects on their behaviour (Jordan et al., 2006; Wu et al., 2009; Cruz et al., 2010) .
Human arylamine N-acetyltransferase 1 (NAT1) is a 33 kDa cytosolic protein with an active site catalytic triad (Sim et al., 2008) . Both the crystal structure and the reaction kinetics ( Fig. 1A and B) have been extensively reported (Rodrigues-Lima et al., 2001; Grant, 2008; Butcher and Minchin, 2012) , making this enzyme an ideal intracellular candidate to investigate the consequences of nanoparticle-enzyme interactions. NAT1 catalyzes the acetylation of substrates by a one-site ping-pong-bi-bi reaction (Fig. 1B) , which requires the cofactor acetyl-coenzyme A (AcCoA). This DMD #55988 mechanism commonly exhibits substrate-dependent inhibition at high concentrations because the substrate binds the active site competitively with the cofactor.
Previously, Sanfins et al. showed NAT1 is inactivated when bound to carbon black nanoparticles (Sanfins et al., 2011) . Since NAT1 can metabolize many different pollutants, these studies suggested that carbon black may increase susceptibility to chemical toxicity. Here, we have used a series of unrelated nanoparticles in an attempt to understand the diversity of effects that protein-nanoparticle interactions can elicit using human NAT1 as a model intracellular enzyme.
Materials and Methods

Nanoparticles
Commercial TiO 2 nanoparticles (Degussa P25) were purchased from Evonik Degussa, SiO 2 nanoparticles (S5130) were purchased from Sigma-Aldrich, ZnO nanoparticles (Nanosun™ 99/30) were kindly supplied by Microniser, Australia. The characterization of these nanoparticles has been reported elsewhere (Deng et al.) . The synthetic layered silicate nanoparticles (LSN) were kindly supplied by Rockwood Additives Ltd. (Laponite-RDS), and dispersed into water by 30 minutes stirring followed by 10 minutes bath sonication. The synthesis and characterization of layered double hydroxide (LDH) nanoparticles are reported elsewhere (Musumeci et al., 2010) .
Thermo-responsive diblock copolymer nanoparticles (TDCN) consisting of poly(dimethylacrylamide) and poly(N-isopropylacrylamide) were synthesized as previously described (Urbani and Monteiro, 2009; Sebakhy et al., 2010) . Transmission electron microscopy was performed as described previously (Deng et al., 2009 ).
DMD #55988
NAT1 activity
Recombinant human NAT1 protein was expressed and purified as previously described (Butcher et al., 2004) . NAT1 activity was determined using p-aminobenzoic acid (PABA) as substrate and AcCoA as cofactor with 10 ng of NAT1 protein. N-acetylated PABA was quantified by high performance liquid chromatography (Butcher et al., 2000) . Reaction rates were determined using variable substrate concentrations and a fixed cofactor concentration (1.1 mM) or variable cofactor concentration and a fixed substrate concentration (0.4 mM). All reactions were performed under linear conditions.
NAT1 binding
Binding of NAT1 to various nanoparticles was determined in 200 µl buffer (20 mM Tris, 1 mM EDTA, 1 mM dithiothreitol, pH 7.4) at 37 o C for 5 minutes following which the solutions were centrifuged at 200 000g at 4 o C for 60 minutes. NAT1 alone was used as a control. The unbound proteins in the supernatant were collected and quantified by Western blot and enzyme activity assay.
NAT1 heat denaturation
Recombinant NAT1 protein (5 ng/100 μl) was heated to several temperatures between 37°C-47°C for 10 minutes in the presence and absence of TDCN (5 μg/100 μl). The temperature was then decreased to 37°C and NAT1 activity assessed as described above.
Data analysis and statistics
DMD #55988
8 nanomaterials are amongst the most widely used in industry and are under development as drug delivery systems and in polymer nanocomposites with industrial and biomedical applications (Patel et al., 2006; Pavlidou and Papaspyrides, 2008) . Both nanoparticles are comprised of plates approximately 1-2 nm in thickness and 30-100 nm in diameter ( Fig. 2A) , 2009; Sebakhy et al., 2010) . When the TDCNs were incubated with NAT1, a significant dose-dependent increase in enzyme activity was seen (Fig. 2B ).
At the highest concentration used (300 μg/ml), activity increased by almost 200% of control.
A plot of the surface Zeta potential against the IC 50 for each of the metal oxide and clay nanoparticle is shown in Fig. 2C . There was a significant positive correlation between these two parameters (R 2 = 0.78, P < 0.05) suggesting the inhibition was related to the negative charge of the nanoparticles. We also determined whether the degree of inhibition was directly proportional to the binding of protein to each nanoparticle. For ZnO, LSN and SiO 2 , the percent bound and the percent inhibition of activity were similar (Fig. 2D) . However, for the LDH and TiO 2 , this was not the case.
Both bound approximately 80% of NAT1 in solution but activity was only inhibited by 21% and 40%, respectively. These results show that, for the latter nanoparticles, binding does not lead to complete inactivation.
Effect of metal oxides on NAT1 enzyme kinetics
The effect of each metal oxide on the acetylation of PABA by NAT1 activity was assessed at a fixed nanoparticle concentration. Table 1 ). The kinetics of PABA acetylation was also determined in the presence of increasing cofactor ( Fig. 3D-F) . Again, there was a parallel shift to the left in the Eadie-Scatchard plots for the 3 metal oxides. Taken together, these data are consistent with binding-induced inactivation of the enzyme by these 3 metal oxides.
Effect of LDH and LSN on NAT1 enzyme kinetics
The LDH affected NAT1 activity in a similar manner as the metal oxides with a shift in the Eadie-Scatchard plots to the left ( Fig. 4A and B) . By contrast, LSN exhibited a more complex interaction with the enzyme. This was demonstrated by the concave nature of the Eadie-Scatchard plot ( Fig. 4C ). At low substrate concentration, the rate of acetylation was not altered by the DMD #55988
nanoparticle whereas, at high substrate concentrations, the reaction rate decreased in a dose-dependent manner (Fig. 4C, insert) . When the kinetics of the cofactor was examined, similar complex nanoparticle-protein interaction was observed (Fig. 3D ). Enzyme activity was not measurable at AcCoA concentrations below 600 μM. The lack of activity at the lower cofactor concentrations was not due to the direct binding of the AcCoA to the nanoparticles since all of it was found in the supernatant following ultra-centrifugation of the nanoparticles (data not shown).
The kinetic curves for NAT1 activity in the presence of LSN suggested substrate-dependent inhibition, which has been reported previously for the arylamine N-acetyltransferases (Jones et al., 1996) . If binding of PABA to the enzyme preceded that for AcCoA, then increasing the concentration of the cofactor should compete for the substrate and result in increased activity. This was seen in Fig. 4D (insert). A substrate-dependent inhibition model (Segel, 1975) was fitted to the data by non-linear least squares regression. For the control (minus nanoparticle), activity was determined up to 800 μM PABA in order to demonstrate substrate-dependent inhibition. The estimated inhibition constant (K i ) was 1011 ± 262.1 µM in the absence of nanoparticle and 189.7 ± 41.25 µM in its presence. These results show that the interaction of NAT1 with LSN increased the binding of substrate to the enzyme before cofactor bound, suggesting conformational rearrangement of the protein structure.
Effect of TDCN on NAT1 enzyme kinetics
The last nanoparticles examined in this study were the self-assembling polymeric nanoparticles TDCN. Unlike any of the other nanoparticles tested, TDCN enhanced the catalytic activity of NAT1 in a dose-dependent manner (Fig. 2B ). Kinetic analysis showed a shift to the right in the Eadie-Scatchard plot for PABA metabolism ( (Table 1) . By contrast, there was a shift to the right when the cofactor concentration was varied, but it was not parallel (Fig. 5B ). This was because the K m for AcCoA significantly decreased in the presence of TDCN (Table 1) .
NAT1 is sensitive to heat denaturation and showed a significant loss in activity as temperature was increased from 37 to 47 o C (Fig. 5C ). However, when incubated with the TDCN, this denaturation was significantly slowed. Taken together, these results suggest the interaction of NAT1
with the TDCN may induced conformational changes that enhanced the enzymatic efficiency of the protein and appeared to stabilize the enzyme so that it was less susceptible to heat denaturation.
Discussion
In the present study, we examined the effect of various nanoparticles on the reaction kinetics of the cytosolic enzyme NAT1. We showed that different nanoparticles induced different responses ranging from inhibition to enhancement of activity. Moreover, we found that LSN, a class of synthetic clay nanoparticles, altered the enzyme reaction to exacerbate substrate-dependent inhibition. All of these differing effects emphasize the multiplicity of nanoparticle-protein interactions and the range of possible outcomes. 
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This article has not been copyedited and formatted. The final version may differ from this version. initially acetylates the active site cysteine (Cys 68 ) after which the product (CoA) is released. The acetyl group is then transferred to the substrate (Sub) and the resulting product is released. Enzymes that utilize this reaction mechanism often show substrate-dependent inhibition because, at high concentrations, the substrate competes with the cofactor for binding at the active site. 
